SCHEMBL104405

SCHEMBL104405

OCC1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5378435 0.89
Oxirane SCHEMBL96722 0.84 ESR1 (0.39)
SCHEMBL536463 0.82
SCHEMBL1458932 0.82
SCHEMBL101449 0.82
Dioxane SCHEMBL5992701 0.80 ESR1 (0.34)
SCHEMBL31368061 0.78 GBA1 (0.35)
SCHEMBL29919218 0.77
SCHEMBL766842 0.77
SCHEMBL18692703 0.77 PDE7A (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2039 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709481-A1 5,6-FUSED AND 6,6-FUSED BICYCLIC ALCOHOLS AND ETHERS AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS Amgen Inc. (US) 2026-03-18 EP claimed
US-20240409557-A1 5,6-FUSED AND 6,6-FUSED BICYCLIC ALCOHOLS AND ETHERS AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS AMGEN INC. (US) 2024-12-12 US claimed
CN-119081799-A Photoresist cleaning solution and preparation method and application thereof 上海盛剑微电子有限公司 2024-12-06 CN claimed
WO-2024233550-A1 5,6-FUSED AND 6,6-FUSED BICYCLIC ALCOHOLS AND ETHERS AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS AMGEN INC. (US) 2024-11-14 WO claimed
CN-118465262-B Method for determining retroviral vector residues in cell preparations 浙江康佰裕生物科技有限公司 2024-10-15 CN claimed
CN-118465262-A Method for determining retroviral vector residues in cell preparations 浙江康佰裕生物科技有限公司 2024-08-09 CN claimed
CN-118045397-A Composite extractant and method for separating metal elements in polyolefin fluid by using same 中国石油天然气股份有限公司 2024-05-17 CN claimed
US-20240051949-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2024-02-15 US claimed
WO-2023217764-A1 NOX INHIBITORS FOR USE IN THE TREATMENT OF ALPORT SYNDROME CALLIDITAS THERAPEUTICS SUISSE SA (CH) 2023-11-16 WO claimed
CN-115971719-A Solder paste for improving welding cavity of large-area bonding pad of electronic device 深圳市唯特偶新材料股份有限公司 2023-04-18 CN claimed
EP-0591805-B1 Process for preparing 4-hydroxymethyl-tetrahydropyran BASF AG (DE) 1996-12-04 EP claimed
EP-0546396-B1 Method for the preparation of 4-hydroxymethyltetrahydropyrans BASF AG (DE) 1996-02-28 EP claimed
EP-0591795-B1 Process for hydrogenolysis of citric acid BASF AG (DE) 1996-01-31 EP claimed
US-5391771-A Reacting citric acid or esters on hydrogenation catalyst in nonaqueous solvent BASF AKTIENGESELLSCHAFT 1995-02-21 US claimed
US-5387701-A Acid catalysis of 3-(2-hydroxyethyl)tetrahydrofuran BASF AKTIENGESELLSCHAFT (DE) 1995-02-07 US claimed
EP-0591805-A1 Process for preparing 4-hydroxymethyl-tetrahydropyran BASF Aktiengesellschaft (DE) 1994-04-13 EP claimed
EP-0591795-A1 Process for hydrogenolysis of citric acid BASF Aktiengesellschaft (DE) 1994-04-13 EP claimed
US-5252755-A Reducing with hydrogen in the presence of hydrogenation catalysts BASF AKTIENGESELLSCHAFT (DE) 1993-10-12 US claimed
US-4413001-A ANTIDEPRESSANTS DELALANDE S.A. (FR) 1983-11-01 US claimed
US-4348393-A ANTIDEPRESSANTS DELALANDE S.A. (FR) 1982-09-07 US claimed